Transplant Complications Working Party (TCWP)
Type d'étude:
Numéro de l'étude:
84110032
Type de traitement à base de cellules souches:
Maladies:
Myelodysplastic (MDS) or MDS/MPN
Other myeloid or lymphoid malignancies
Titre court:
Uric Acid Study
Objectif principal:
To assess if uric acid acting as danger signal and released during conditioning therapy is associated with occurence and severity of acute GvHD
Principaux critères d'inclusion:
First allo-SCT from HLA-matched sibling donors given stem cell grafts (bone marrow or peripheral blood) without T cell depletion, patients with AL, MDS or Lymphoma, Myeloablative and dose-reduced conditioning
Pays:
Investigateur principal:
Olaf Penack
Coordinateur EBMT de l'étude:
Steffie van der Werf